Literature DB >> 33728519

An Item Response Theory-Informed Strategy to Model Total Score Data from Composite Scales.

Gustaf J Wellhagen1, Sebastian Ueckert1, Maria C Kjellsson1, Mats O Karlsson2.   

Abstract

Composite scale data is widely used in many therapeutic areas and consists of several categorical questions/items that are usually summarized into a total score (TS). Such data is discrete and bounded by nature. The gold standard to analyse composite scale data is item response theory (IRT) models. However, IRT models require item-level data while sometimes only TS is available. This work investigates models for TS. When an IRT model exists, it can be used to derive the information as well as expected mean and variability of TS at any point, which can inform TS-analyses. We propose a new method: IRT-informed functions of expected values and standard deviation in TS-analyses. The most common models for TS-analyses are continuous variable (CV) models, while bounded integer (BI) models offer an alternative that respects scale boundaries and the nature of TS data. We investigate the method in CV and BI models on both simulated and real data. Both CV and BI models were improved in fit by IRT-informed disease progression, which allows modellers to precisely and accurately find the corresponding latent variable parameters, and IRT-informed SD, which allows deviations from homoscedasticity. The methodology provides a formal way to link IRT models and TS models, and to compare the relative information of different model types. Also, joint analyses of item-level data and TS data are made possible. Thus, IRT-informed functions can facilitate total score analysis and allow a quantitative analysis of relative merits of different analysis methods.

Entities:  

Keywords:  IRT-informed total score analysis; bounded integer model; composite scale data; total score analysis

Year:  2021        PMID: 33728519      PMCID: PMC7966126          DOI: 10.1208/s12248-021-00555-3

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  8 in total

1.  Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.

Authors:  Thuy C Vu; John G Nutt; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

2.  Composite rating scales.

Authors:  Pablo Martinez-Martin
Journal:  J Neurol Sci       Date:  2009-09-03       Impact factor: 3.181

3.  Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients.

Authors:  Simon Buatois; Sylvie Retout; Nicolas Frey; Sebastian Ueckert
Journal:  Pharm Res       Date:  2017-07-10       Impact factor: 4.200

4.  Relating nicotine plasma concentration to momentary craving across four nicotine replacement therapy formulations.

Authors:  Eva Germovsek; Anna Hansson; Maria C Kjellsson; Juan Jose Perez Ruixo; Åke Westin; Paul A Soons; An Vermeulen; Mats O Karlsson
Journal:  Clin Pharmacol Ther       Date:  2019-07-29       Impact factor: 6.875

5.  An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM.

Authors:  Daniela J Conrado; William S Denney; Danny Chen; Kaori Ito
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-29       Impact factor: 2.745

6.  The heterogeneity of Parkinson's disease: clinical and prognostic implications.

Authors:  W J Zetusky; J Jankovic; F J Pirozzolo
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

7.  Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.

Authors:  Samantha K Holden; Taylor Finseth; Stefan H Sillau; Brian D Berman
Journal:  Mov Disord Clin Pract       Date:  2017-09-22

8.  The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Authors:  Kenneth Marek; Sohini Chowdhury; Andrew Siderowf; Shirley Lasch; Christopher S Coffey; Chelsea Caspell-Garcia; Tanya Simuni; Danna Jennings; Caroline M Tanner; John Q Trojanowski; Leslie M Shaw; John Seibyl; Norbert Schuff; Andrew Singleton; Karl Kieburtz; Arthur W Toga; Brit Mollenhauer; Doug Galasko; Lana M Chahine; Daniel Weintraub; Tatiana Foroud; Duygu Tosun-Turgut; Kathleen Poston; Vanessa Arnedo; Mark Frasier; Todd Sherer
Journal:  Ann Clin Transl Neurol       Date:  2018-10-31       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.